Active Ownership Blog banner

Proxy Power: How Shareholders Are Using Active Ownership to Take On the Opioid Epidemic

06/05/2019

The Sisters of St. Francis of Philadelphia are far from the largest shareholders of AmerisourceBergen (NYSE: ABC), one of the country’s so-called big three drug distributors. But that didn’t stop the Aston, Pennsylvania, community of approximately 400 Catholic women from exercising their shareholder rights. In 2017 they asked the company’s management to produce a report that examined the role AmerisourceBergen plays in the opioid supply chain. They also requested that the company consider the risks it faces as a distributor of opioids.


Nuns aren’t the only shareholders AmerisourceBergen and other drug companies are contending with. The International Brotherhood of Teamsters as well as the treasurers of multiple states are leading shareholder campaigns aimed at opioid distributors.


As you can imagine, there isn’t much overlap in membership between these three groups, but they share a common goal when it comes to tackling the nation’s opioid crisis. So it made sense for them to band together to form the Investors for Opioid Accountability (IOA), a coalition of investors seeking to hold pharmaceutical manufacturers, distributors, and retailers accountable for risks to their shareholders and to society at large as a result of their business involvement with opioid medication. Today, the IOA represents 54 institutional investors of all types, amounting to $3.5 trillion in invested assets. It has pressed drug distributors on issues such as separating the roles of CEO and board chair, disclosing when executive incentives have been recouped (clawbacks), and considering legal settlements when calculating executive pay.


At the heart of the IOA’s requests is a straightforward, timeless corporate governance message—that executives should be rewarded for creating long-lasting company value and, importantly, not be tempted to put the company into risky, shortsighted positions. But the IOA’s origin story is also a great answer to a question investors often ask themselves: How can I change corporate behavior? After all, I own only a fraction of this company—why would management bother to listen to what I have to say?


What one proxy vote can do

You may not have the time or the wherewithal to sit down with company management or put together a shareholder proposal. But you can still practice active ownership. You have the power of the proxy vote, which gives you the right to vote on other shareholders’ proposals and for (or against) board members who may (or may not be) aligned with your way of thinking about corporate governance.


So what can one vote do? Perhaps not much alone, but a lot together. You can, of course, choose to vote your own proxies. Or you can give proxy-voting authority to an asset manager if you’re convinced that manager’s tenets around proxy voting align with yours. Because they have authority to vote for many of the investors they work with, such managers bring more clout to proxies, helping you, like the Sisters of St. Francis, wield greater power than you could alone.


Vote graphic

The results of active ownership

The Sisters of St. Francis proposal garnered a very strong 40% support—a figure that’s all the more impressive considering it was the first time it had been on the AmerisourceBergen ballot. In turn, the drug company has since promised to create the requested report by the end of the third quarter of 2019.


Meanwhile, the IOA successfully persuaded AmerisourceBergen to separate its CEO and board chair positions. The company was a holdout among its peers, who had already made this crucial reform. Opioid manufacturer Teva Pharmaceuticals responded to a similar proposal that wouldn’t exclude legal settlements in executive pay calculations.


The bottom line

According to the Centers for Disease Control and Prevention, more than 47,000 people died in the US from opioid-related overdoses in 2017, or about 130 a day. The big three drug wholesalers—AmerisourceBergen, McKesson, and Cardinal Health—control more than 80% of the market that moves pharmaceuticals from manufacturers to pharmacies and hospitals. That’s a lot of accountability, and shareholders (even smaller ones) have demonstrated that, when they work together, they can use active ownership to hold those companies accountable. Every vote counts, and this becomes especially true when good corporate governance becomes a matter of life or death. 


Martha Strebinger

Martha Strebinger, CFA, Senior Investment Strategist

Martha is responsible for assisting in the continued evolution of Parametric’s Responsible Investing capabilities. Prior to joining Parametric in 2016, she was an investment specialist at Truepoint Wealth Counsel in Cincinnati and worked in Boston at Wellington Management Company and Grantham, Mayo, and Van Otterloo (GMO). She earned a BS in human biology, health, and society from Cornell University. A CFA charterholder, Martha is a member of the CFA Society of Seattle.


The views expressed in these posts are those of the authors and are current only through the date stated. These views are subject to change at any time based upon market or other conditions, and Parametric and its affiliates disclaim any responsibility to update such views. These views may not be relied upon as investment advice and, because investment decisions for Parametric are based on many factors, may not be relied upon as an indication of trading intent on behalf of any Parametric strategy. The discussion herein is general in nature and is provided for informational purposes only. There is no guarantee as to its accuracy or completeness. Past performance is no guarantee of future results. All investments are subject to the risk of loss.

{F33BD959-1499-4857-91FB-3B0EF4ADCB43}

Loading...